Cargando…

170. Predictors of Recurrent Infective Endocarditis in Intravenous Drug Users

BACKGROUND: Caring for hospitalized patients with infective endocarditis (IE) can be challenging due to the nature of the disease and its complications, underlying medical and psychiatric problems, socioeconomic status and environmental factors.Some of these patients develop recurrent IE after the f...

Descripción completa

Detalles Bibliográficos
Autores principales: Kongpakpaisarn, Kullatham, Aslam, Sadaf, Tariq, Musaab, Mhaskar, Rahul, Shin, Doosup, Bohra, Chandrashekar, Somboonwit, Charurut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809855/
http://dx.doi.org/10.1093/ofid/ofz360.245
_version_ 1783462099216760832
author Kongpakpaisarn, Kullatham
Aslam, Sadaf
Tariq, Musaab
Mhaskar, Rahul
Shin, Doosup
Bohra, Chandrashekar
Somboonwit, Charurut
author_facet Kongpakpaisarn, Kullatham
Aslam, Sadaf
Tariq, Musaab
Mhaskar, Rahul
Shin, Doosup
Bohra, Chandrashekar
Somboonwit, Charurut
author_sort Kongpakpaisarn, Kullatham
collection PubMed
description BACKGROUND: Caring for hospitalized patients with infective endocarditis (IE) can be challenging due to the nature of the disease and its complications, underlying medical and psychiatric problems, socioeconomic status and environmental factors.Some of these patients develop recurrent IE after the first episode treated. On-going intravenous (IV) drug use after hospital discharge is the highest predictive factor for recurrent IE. Besides IV drug use, there are limited data of other contributing factors to recurrent IE. Those factors may be modifiable during the first hospitalization to reduce the incidence of recurrent IE. METHODS: A retrospective cohort study was conducted at a large tertiary acute care medical center in Tampa, Florida. All consecutive patients with IE with history of IV drug use from January, 2011 to December, 2017 were included. Basic demographic information, co-morbidities (diabetes, hypertension, chronic lung and kidney diseases, HIV, Hepatitis B and C status, coronary artery diseases), valves involved, length of stay, complications at their first IE episode such as septic shock and stroke were included. Groups were identified based on the first episode, first recurrence and second or more recurrences of IE. RESULTS: A total of 106 patients were identified based on the inclusion criteria. The association between the type of valve infection (right side and left side) and IE recurrence was found to be statistically significant. (P = 0.003). Right side valves are prone to have recurrent IE episodes. People with recurrent IE were more likely to have septic shock (P = 0.02) and requiring intensive care unit (ICU) admissions (P < 0.001) during their first episode There was no statistically significant difference between other demographic information and recurrent endocarditis as well as other parameters such as organisms or type of substance used. (Table 1) CONCLUSION: Right-sided IE and presence of septic shock during their first episode of IE may be the predictors for recurrent IE. Interventions including closer follow-up, more aggressive septic shock recognition and management, socioeconomic assessment in addition to substance abuse treatments after discharge should be considered to prevent recurrent IE. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6809855
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68098552019-10-28 170. Predictors of Recurrent Infective Endocarditis in Intravenous Drug Users Kongpakpaisarn, Kullatham Aslam, Sadaf Tariq, Musaab Mhaskar, Rahul Shin, Doosup Bohra, Chandrashekar Somboonwit, Charurut Open Forum Infect Dis Abstracts BACKGROUND: Caring for hospitalized patients with infective endocarditis (IE) can be challenging due to the nature of the disease and its complications, underlying medical and psychiatric problems, socioeconomic status and environmental factors.Some of these patients develop recurrent IE after the first episode treated. On-going intravenous (IV) drug use after hospital discharge is the highest predictive factor for recurrent IE. Besides IV drug use, there are limited data of other contributing factors to recurrent IE. Those factors may be modifiable during the first hospitalization to reduce the incidence of recurrent IE. METHODS: A retrospective cohort study was conducted at a large tertiary acute care medical center in Tampa, Florida. All consecutive patients with IE with history of IV drug use from January, 2011 to December, 2017 were included. Basic demographic information, co-morbidities (diabetes, hypertension, chronic lung and kidney diseases, HIV, Hepatitis B and C status, coronary artery diseases), valves involved, length of stay, complications at their first IE episode such as septic shock and stroke were included. Groups were identified based on the first episode, first recurrence and second or more recurrences of IE. RESULTS: A total of 106 patients were identified based on the inclusion criteria. The association between the type of valve infection (right side and left side) and IE recurrence was found to be statistically significant. (P = 0.003). Right side valves are prone to have recurrent IE episodes. People with recurrent IE were more likely to have septic shock (P = 0.02) and requiring intensive care unit (ICU) admissions (P < 0.001) during their first episode There was no statistically significant difference between other demographic information and recurrent endocarditis as well as other parameters such as organisms or type of substance used. (Table 1) CONCLUSION: Right-sided IE and presence of septic shock during their first episode of IE may be the predictors for recurrent IE. Interventions including closer follow-up, more aggressive septic shock recognition and management, socioeconomic assessment in addition to substance abuse treatments after discharge should be considered to prevent recurrent IE. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809855/ http://dx.doi.org/10.1093/ofid/ofz360.245 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Kongpakpaisarn, Kullatham
Aslam, Sadaf
Tariq, Musaab
Mhaskar, Rahul
Shin, Doosup
Bohra, Chandrashekar
Somboonwit, Charurut
170. Predictors of Recurrent Infective Endocarditis in Intravenous Drug Users
title 170. Predictors of Recurrent Infective Endocarditis in Intravenous Drug Users
title_full 170. Predictors of Recurrent Infective Endocarditis in Intravenous Drug Users
title_fullStr 170. Predictors of Recurrent Infective Endocarditis in Intravenous Drug Users
title_full_unstemmed 170. Predictors of Recurrent Infective Endocarditis in Intravenous Drug Users
title_short 170. Predictors of Recurrent Infective Endocarditis in Intravenous Drug Users
title_sort 170. predictors of recurrent infective endocarditis in intravenous drug users
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809855/
http://dx.doi.org/10.1093/ofid/ofz360.245
work_keys_str_mv AT kongpakpaisarnkullatham 170predictorsofrecurrentinfectiveendocarditisinintravenousdrugusers
AT aslamsadaf 170predictorsofrecurrentinfectiveendocarditisinintravenousdrugusers
AT tariqmusaab 170predictorsofrecurrentinfectiveendocarditisinintravenousdrugusers
AT mhaskarrahul 170predictorsofrecurrentinfectiveendocarditisinintravenousdrugusers
AT shindoosup 170predictorsofrecurrentinfectiveendocarditisinintravenousdrugusers
AT bohrachandrashekar 170predictorsofrecurrentinfectiveendocarditisinintravenousdrugusers
AT somboonwitcharurut 170predictorsofrecurrentinfectiveendocarditisinintravenousdrugusers